(OTCBB:HFGB) Huifeng Bio-Pharmaceutical Technology, Inc.

RealPennies.com: (OTCBB:HFGB) Huifeng Bio-Pharmaceutical Technology, Inc.
Are you a public company looking for exposure?
Contact RealPennies.com - 1-646-417-8211

For more info: http://hfgb.realpennies.com/

Huifeng Bio-Pharmaceutical to Attend CPhI South America 2008 Pharmaceutical Conference; The First CPhI Conference to be held in the Emerging Market of Brazil
Wednesday August 20, 8:30 am ET

XI'AN, China, Aug. 20 - Huifeng Bio-Pharmaceutical Technology, Inc , a leading developer and producer of plant extracts and pharmaceutical raw materials for use in pharmaceutical, nutraceutical and food production, recently announced it will be in attendance at the CPhI South America Conference, August 19-21 in Rio de Janeiro, Brazil.
"Unparalleled business opportunities for all companies involved in the pharmaceutical raw materials industry are now presenting themselves throughout South America, particularly in Brazil, " stated Jing' An Wang, CEO, Huifeng. "Huifeng is becoming recognized as a leading industry player and has much to offer the South American, as well as to the global, pharmaceutical market."
"We are excited to begin cultivating new relationships with corporations from around the world during this important conference," said Mr. Wang.

According to CPhI, there are more than 180 million people living in Brazil alone. With a rapidly emerging market second only to China and a growth rate exceeding that of the global average, South America continues to promote an attractive business arena.
Due to the rapid amount of global investment taking place in Brazil much is to be gained by establishing new business partnerships with local suppliers, buyers and manufacturers.

About CMP Information and CPhI Pharmaceutical Conferences
CMP Information, part of United Business Media plc, a London Stock Exchange listed media company, is responsible for the organization of the world's leading CPhI, ICSE, Hi and Fi series of pharmaceutical and food ingredient trade shows. CPhI is the leading international exhibition provider in the pharmaceutical ingredients and allied industries markets. This is the first CPhI conference to take place in South America.

About Huifeng Bio-Pharmaceutical Technology, Inc.
Huifeng Bio-Pharmaceutical Technology, Inc., located in Xi'an, People's Republic of China, develops and produces plant extracts and pharmaceutical raw materials for use in pharmaceutical, nutraceutical and food production. It is the leading Chinese producer of rutin and related plant-derived chemicals in a class called flavonoids, with medicinal and other beneficial properties. Founded in 2002, Huifeng uses proprietary patented processes to extract rutin more efficiently than traditional extraction techniques. The Company is diversifying its product lines through internal development, acquisition and cooperation with scientific research organizations. http://www.hfgb.cn/

LAST $0.66 USD

Read our full disclaimer at: http://www.realpennies.com

Investors are advised that this analysis is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy. This report does not have regard to the specific investment objectives, financial situation and the particular needs of any specific person who may receive this information. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Past performance is no guarantee of future results. Please consult a broker before purchasing or selling any securities mentioned on
http://www.realpennies.com/content/view/42

Any opinions expressed herein are statements of our judgment as of the date of publication and are subject to change without notice. Reproduction without written permission is prohibited.

RealPennies .
Telephone: 1-646-417-8211
news /at/ realpennies.com